BioNotebook: Two key fires at Retrophin, NewLink; three deals and three financings

Boards of directors fire Retrophin CEO Shkreli, NewLink CFO Gordon Link; Rockwell, Baxter sign commercial deal; MacroGenics, Takeda enter second alliance; Sagent buys Omega; Portola, Titan price offerings; and Ignyta secures new debt.